(Q35043379)

6 August 2017

0 references

1 reference

title

Meta-analysis of interventions to improve drug adherence in patients with hyperlipidemia (English)

1 reference

6 August 2017

1 reference

Andrew M Peterson

1

1 reference

6 August 2017

Liza Takiya

series ordinal

2

1 reference

6 August 2017

Rebecca Finley

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

23

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

80-87

1 reference

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Comparison of evidence of treatment effects in randomized and nonrandomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

A critical evaluation of the methodology of the literature on medication compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Persistence of use of lipid-lowering medications: a cross-national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Effectiveness of interventions to improve patient compliance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.80.31921

10.1592/PHCO.23.1.80.31921

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference